CPN's clinical trial Study Coordinators and Clinical Research Assistants have a critically important role. They are the individuals on the front line of patient care who make it possible for the Physician investigators to do cancer prevention research. Study Coordinators take responsibility for educating patients, keeping accurate and complete files and records, and insuring compliance with all regulations regarding patient safety and confidentiality.
On behalf of CPN, thank you.
The following documents are available for Study Coordinators:
Roster and Regulatory Forms:
|
For MAY03-1-02 CPN Lung/Sulindac Study: |
| For MAY04-4-01 CPN Barrett's esophagus Study: | |
| Pharmacy: Drug Accountability, Audit, and Return Forms: |
MAY06-8-01 CPN Myo-inositol Study: |
| Deviations and Adverse Event Reporting: | Go to the
Members Only section for the following documents:
|
| Common
Terminology Criteria for Adverse Events (CTCAE): CTCAE Versions 3.0 and 4.03 are available from NCI. |
If there are any other documents or forms needed, please contact the CPN Operations Office.
Thank you and good luck.